Elena V Batrakova Selected Research

Elena V Batrakova Research Topics

Disease

19	Neoplasms (Cancer) 01/2020 - 08/2002
14	Parkinson Disease (Parkinson's Disease) 03/2022 - 09/2007
5	Neuroinflammatory Diseases 01/2022 - 09/2011
5	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2005
4	Inflammation (Inflammations) 01/2023 - 01/2011
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2004
3	Neuronal Ceroid-Lipofuscinoses (Neuronal Ceroid Lipofuscinosis) 01/2023 - 01/2019
3	Encephalitis (Encephalitis, Rasmussen) 12/2019 - 05/2007
2	Triple Negative Breast Neoplasms 01/2020 - 01/2020
2	Disease Progression 01/2014 - 04/2010
2	Leukemia 11/2011 - 11/2008
1	Obesity 12/2022
1	Sleep Apnea Syndromes (Sleep Apnea) 12/2022
1	Colonic Neoplasms (Colon Cancer) 11/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Lung Neoplasms (Lung Cancer) 01/2018
1	Communicable Diseases (Infectious Diseases) 01/2015
1	Brain Injuries (Brain Injury) 09/2012
1	Lewis Lung Carcinoma 05/2010
1	T-Cell Leukemia (Leukemia, T Cell) 05/2010
1	Carcinoma (Carcinomatosis) 11/2008
1	Hyperlipidemias (Hyperlipidemia) 10/2008
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 05/2007

Drug/Important Bio-Agent (IBA)

14	Poloxamer (Poloxamer 407)IBA 01/2020 - 08/2002
9	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 08/2003
9	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 08/2002
8	AntioxidantsIBA 01/2018 - 09/2007
7	EnzymesIBA 01/2023 - 01/2011
7	CatalaseIBA 09/2017 - 01/2011
5	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 03/2022 - 01/2014
3	Neuroprotective AgentsIBA 03/2022 - 01/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2020 - 04/2016
3	MicellesIBA 01/2020 - 12/2004
2	Drug CarriersIBA 01/2020 - 11/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 09/2011
2	SP 1049CIBA 01/2020 - 11/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 03/2006
2	Ethylene Oxide (Oxirane)IBA 05/2010 - 01/2005
2	Adenosine Triphosphate (ATP)IBA 05/2010 - 08/2003
2	polypropylene glycol (poly(propylene oxide))IBA 05/2010 - 01/2005
2	Surface-Active Agents (Surfactants)IBA 11/2008 - 12/2004
2	PolymersIBA 05/2007 - 03/2006
2	Anti-Bacterial Agents (Antibiotics)IBA 08/2003 - 09/2002
2	AnthracyclinesIBA 08/2003 - 09/2002
1	Therapeutic UsesIBA 01/2023
1	LipofuscinIBA 01/2023
1	LeptinIBA 12/2022
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	SynucleinsIBA 12/2019
1	Small Interfering RNA (siRNA)IBA 11/2019
1	IntegrinsIBA 11/2019
1	Nucleic AcidsIBA 11/2019
1	CalciumIBA 11/2019
1	Messenger RNA (mRNA)IBA 11/2019
1	sigma Receptors (sigma Receptor)IBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2018
1	Nerve Growth Factors (Neurotrophins)IBA 01/2014
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 06/2012
1	Gemcitabine FDA Link 11/2011
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 05/2010
1	CaspasesIBA 05/2010
1	Rhodamine 123IBA 11/2008
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 11/2008
1	Zidovudine (Retrovir)FDA LinkGeneric 05/2007
1	Lamivudine (Epivir)FDA Link 05/2007
1	Nelfinavir (Viracept)FDA Link 05/2007
1	Excipients (Suspending Agents)IBA 03/2006
1	polyethylene glycol polyethyleneimine nanogelIBA 09/2005
1	NanogelsIBA 09/2005
1	Folic Acid (Vitamin M)FDA LinkGeneric 09/2005
1	pluronic block copolymer p85IBA 07/2005
1	OligonucleotidesIBA 01/2004
1	multidrug resistance-associated protein 1IBA 10/2003

Therapy/Procedure

9	Therapeutics 01/2022 - 05/2007
5	Drug Therapy (Chemotherapy) 05/2010 - 08/2003
1	Spinal Injections 01/2023
1	Drug Administration Routes 01/2020
1	Enzyme Replacement Therapy 01/2020
1	Highly Active Antiretroviral Therapy (HAART) 01/2015
1	Art Therapy 05/2007